REGENXBIO Inc.

REGENXBIO Inc.verified

RGNX

Price:

$7.4

Market Cap:

$366.63M

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, which is in Phase III clinical trial for the treatment of wet age-related macular degeneration. It is also developing RGX-121 that is in Phase I/II clinical trial to treat mucopolysaccharidosis type II;RGX-111, which is in Phase I/II clinical trial for...[Read more]

Industry

Biotechnology

IPO Date

2015-09-17

Stock Exchange

NASDAQ

Ticker

RGNX

The ROE as of December 2024 (TTM) for REGENXBIO Inc. (RGNX) is -70.65%

According to REGENXBIO Inc.’s latest financial reports and current stock price. The company's current ROE is -70.65%. This represents a change of 295.94% compared to the average of -17.84% of the last 4 quarters.

REGENXBIO Inc. (RGNX) Historical ROE (quarterly & annually)

How has RGNX ROE performed in the past?

The mean historical ROE of REGENXBIO Inc. over the last ten years is -17.21%. The current -70.65% ROE has changed 310.43% with respect to the historical average. Over the past ten years (40 quarters), RGNX's ROE was at its highest in in the December 2014 quarter at 41.00%. The ROE was at its lowest in in the December 2023 quarter at -20.17%.

Quarterly (TTM)
Annual

Average

-17.21%

Median

-25.25%

Minimum

-84.52%

Maximum

70.25%

REGENXBIO Inc. (RGNX) ROE by Quarter and Year

Discovering the peaks and valleys of REGENXBIO Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 270.03%

Maximum Annual ROE = 70.25%

Minimum Annual Increase = -424.67%

Minimum Annual ROE = -84.52%

Quarterly (TTM)
Annual
YearROEChange
2023-84.52%55.64%
2022-54.31%-424.67%
202116.73%-156.80%
2020-29.45%39.96%
2019-21.04%-207.14%
201819.64%-149.13%
2017-39.98%2.68%
2016-38.93%270.03%
2015-10.52%-114.98%
201470.25%-72.05%

REGENXBIO Inc. (RGNX) Average ROE

How has RGNX ROE performed in the past?

The current ROE of REGENXBIO Inc. (RGNX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-40.70%

5-year avg

-34.52%

10-year avg

-17.21%

REGENXBIO Inc. (RGNX) ROE vs. Peers

How is RGNX’s ROE compared to its peers?

REGENXBIO Inc.’s ROE is greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than Replimune Group, Inc. (-53.12%), greater than Mirum Pharmaceuticals, Inc. (-41.22%), greater than Rocket Pharmaceuticals, Inc. (-62.62%), greater than Avidity Biosciences, Inc. (-27.66%), greater than uniQure N.V. (-188.82%), less than Protagonist Therapeutics, Inc. (34.68%), greater than Pliant Therapeutics, Inc. (-48.91%), greater than Immunocore Holdings plc (-14.67%), greater than Revolution Medicines, Inc. (-33.67%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), greater than Stoke Therapeutics, Inc. (-54.45%), greater than AN2 Therapeutics, Inc. (-57.63%), greater than Passage Bio, Inc. (-72.53%), greater than 4D Molecular Therapeutics, Inc. (-28.00%), greater than Crinetics Pharmaceuticals, Inc. (-36.12%), greater than LianBio (-21.53%), greater than Kezar Life Sciences, Inc. (-59.73%),

Build a custom stock screener for REGENXBIO Inc. (RGNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like REGENXBIO Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

REGENXBIO Inc. (RGNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like REGENXBIO Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is REGENXBIO Inc.'s ROE?

How is the ROE calculated for REGENXBIO Inc. (RGNX)?

What is the highest ROE for REGENXBIO Inc. (RGNX)?

What is the 3-year average ROE for REGENXBIO Inc. (RGNX)?

What is the 5-year average ROE for REGENXBIO Inc. (RGNX)?

How does the current ROE for REGENXBIO Inc. (RGNX) compare to its historical average?